Condition
Vertebral Metastases
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 74/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results67% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 1 (1)
Trial Status
Completed2
Terminated1
Not Yet Recruiting1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06910618Not Yet RecruitingPrimary
A Multicenter Prospective Observational Study on Vertebral Fracture Risk Stratification in Patients With Vertebral Metastases
NCT02616887TerminatedPrimary
Study of Image-Guided SBRT for Vertebral Metastases
NCT01347307Not ApplicableCompleted
Stereotactic Body Radiotherapy for Spine Tumors
NCT02464761Phase 1CompletedPrimary
Photodynamic Therapy for the Treatment of Vertebral Metastases
Showing all 4 trials